Prognosis of the influence of direct oral anticoagulants on the direct medical expenses in patients with atrial fibrillation

Prognosis of the influence of direct oral anticoagulants on the direct medical expenses in patients with atrial fibrillation

Aim. To evaluate clinical-economical effectiveness of direct oral anticoagulants (DOAC) dabigatran, rivaroxaban, and apixaban in comparison with warfarin in atrial fibrillation (AF) therapy.Materials and Methods. Mathematical modeling (tree derivation of solutions) on a temporary 5-year horizon from...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. V. Malchikova, A. N. Korobeinikova, N. S. Maksimchuk-Kolobova, M. V. Kazakovtseva
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2020-08-01
Series:	Фармакоэкономика
Subjects:	atrial fibrillation oral anticoagulants mathematic modeling
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/385
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comorbidity in elderly patients with atrial fibrillation affects the “cost of illness”
by: S. V. Malchikova, et al.
Published: (2019-10-01)

Inappropriate dosing of direct oral anticoagulants among very older inpatients with atrial fibrillation
by: Ya-Tong Zhang, et al.
Published: (2025-04-01)

NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING
by: Zh. D. Kobalava, et al.
Published: (2018-05-01)

Safety of direct oral anticoagulants in patients with atrial fibrillation and high risk of stroke (review of literature)
by: E. I. Baranova, et al.
Published: (2020-02-01)

Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease
by: V. I. Petrov, et al.
Published: (2019-09-01)

Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy
by: E. S. Mazur, et al.
Published: (2021-11-01)

EFFICACY AND SAFETY OF DIRECT ORAL ANTICOAGULANTS IN THE PREVENTION OF STROKE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION IN EVERYDAY CLINICAL PRACTICE: FACTS ABOUT RIVAROXABAN
by: I. S. Yavelov
Published: (2016-07-01)

Stroke prevention for non-valvular atrial fibrillation: how to make the right choice of directly acting oral anticoagulants?
by: N. N. Kryukov, et al.
Published: (2019-02-01)

Prognosis of Patients With Ischemic Stroke With Prior Anticoagulant Therapy: Direct Oral Anticoagulants Versus Warfarin
by: Kyeong‐Hyeon Chun, et al.
Published: (2024-08-01)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2020-05-01)

PHARMACODYNAMICS OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ACUTE PERIOD OF ISCHEMIC STROKE
by: V. I. Petrov, et al.
Published: (2021-01-01)

Direct oral anticoagulants for electrical cardioversion
by: A. N. Volovchenko, et al.
Published: (2021-07-01)

Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Without Mechanical Valves
by: Ghadeer K. Dawwas, et al.
Published: (2025-02-01)

Hypertension, chronic kidney disease, atrial fibrillation and the newer anticoagulants
by: B. Rayner
Published: (2012-10-01)

MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION
by: E. A. Belikov, et al.
Published: (2015-09-01)

Modern Anticoagulant Therapy for Atrial Fibrillation: Patient Adherence in Clinical Practice
by: Yu. P. Skirdenko, et al.
Published: (2022-03-01)

Assessment of Long‐Term Use Versus Discontinuation of Direct Oral Anticoagulant After Catheter Ablation for Atrial Fibrillation—RYOUMA Registry Subanalysis
by: Yuka Oda, et al.
Published: (2025-05-01)

Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
by: Anetta Undas, et al.
Published: (2019-12-01)

The Effect of Direct Anticoagulant Therapy on Haematological Parameters in Atrial Fibrillation: Clinical Significance of Subclinical Haemoglobin Decrease
by: Metin Çoksevim, et al.
Published: (2024-11-01)

Factors determining adherence to anticoagulant therapy in patients with atrial fibrillation
by: D. V. Pevzner, et al.
Published: (2023-06-01)

The use of oral anticoagulants in patients with atrial fibrillation: cohort study data
by: O. V. Gaisenok, et al.
Published: (2016-09-01)

A patient with atrial fibrillation and diabetes: selecting the optimal anticoagulant therapy regimen
by: A. G. Obrezan, et al.
Published: (2021-06-01)

ANALYSIS OF THE FREQUENCY OF USING VARIOUS ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN REAL PRACTICE
by: A. N. Atakanova, et al.
Published: (2017-12-01)

POSSIBILITY OF NOVEL ORAL ANTICOAGULANTS USAGE DURING ABLATION IN ATRIAL FIBRILLATION
by: B. A. Tatarsky, et al.
Published: (2014-12-01)

NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
by: D. A. Itkin, et al.
Published: (2015-02-01)

Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient‐Level Meta‐Analysis From COMBINE AF
by: Linda S. Johnson, et al.
Published: (2024-09-01)

Anticoagulation for Stroke Prevention in Patients with Atrial Fibrillation: A Review of the Literature and Current Guidelines
by: Vrinda Vyas, et al.
Published: (2025-06-01)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
by: Paula Tiili, et al.
Published: (2021-01-01)

Anticoagulant therapy in catheter ablation of atrial fibrillation and flutter
by: M. V. Serova, et al.
Published: (2021-09-01)

PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS
by: A. А. Sokolova, et al.
Published: (2017-12-01)

Oral Anticoagulation Choice and Dosage in Very Elderly Patients with Atrial Fibrillation
by: Martha Zergioti, et al.
Published: (2025-02-01)

COMPARISON OF SCHEMES OF PERIOPERATIONAL ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS DEMANDING FOR SURGERY
by: L. N. Uddin, et al.
Published: (2018-06-01)

Non-adherence and non-persistence of Direct Oral Anticoagulants among patients with non-valvular atrial fibrillation: a French retrospective cohort study
by: Victoria A. Fuchs, et al.
Published: (2025-03-01)

Prevention of Cardioembolic Complications in Patients with Atrial Fibrillation: Efficacy and Safety of Left Atrial Appendage Isolation and Oral Anticoagulants
by: D. V. Pevzner, et al.
Published: (2022-09-01)

Ten‐Year Trend of Oral Anticoagulation Use in Postoperative and Nonpostoperative Atrial Fibrillation in Routine Clinical Practice
by: Xiaoxi Yao, et al.
Published: (2024-07-01)

Contribution of anticoagulant therapy adherence to the risk of complications of atrial fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2019-03-01)

The Controversy Continues Again: which Direct Anticoagulant is More Effective and Safe when Administered to Patients with Atrial Fibrillation?
by: S. Yu. Martsevich
Published: (2020-09-01)

Adherence to Treatment with New Oral Anticoagulants in Atrial Fibrillation Patients in Real Clinical Practice (Results of the ANTEY Study)
by: S. Yu. Martsevich, et al.
Published: (2020-01-01)

THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN CLINICAL PRACTICE
by: S. V. Moiseev
Published: (2016-05-01)

Thrombodynamics Test in Assessing the Risk of Thrombus Formation in Patients with Atrial Fibrillation Taking Direct Oral Anticoagulants
by: Z. A. Gebekova, et al.
Published: (2022-11-01)